Company Filing History:
Years Active: 2009-2013
Title: **Inventor Profile: Ronnie Tung Ping Poon**
Introduction
Ronnie Tung Ping Poon is an innovative inventor based in Hong Kong, China, recognized for his contributions to medical science and cancer treatment. With a focus on specific cancer therapies, he has developed unique technologies aimed at improving patient outcomes. His dedication to research is evidenced by his notable patent portfolio comprising three significant inventions.
Latest Patents
One of his latest patents, titled "Cytotoxicity mediation of cells evidencing surface expression of CD44," addresses the diagnosis and treatment of cancerous diseases. This invention emphasizes the mediation of cytotoxicity in both primary and metastatic human tumor cells. It particularly focuses on the application of isolated monoclonal antibodies, known as cancerous disease-modifying antibodies (CDMAB), which can be used alone or in conjunction with chemotherapeutic agents to initiate cytotoxic responses in human tumors. The invention also relates to binding assays employing the CDMAB, presenting a promising avenue for targeted cancer therapy.
Career Highlights
Currently, Ronnie Tung Ping Poon is associated with Hoffmann-La Roche Inc., a leading global healthcare company known for its biomedical innovations. His career has been marked by significant contributions to cancer research, highlighting his commitment to finding effective treatment solutions for patients suffering from various forms of cancer.
Collaborations
Throughout his career, Ronnie has collaborated with notable professionals in the field such as David S F Young and Daad Sayegh. These collaborations have likely enriched his research perspectives and advanced his innovative efforts in cancer treatment.
Conclusion
Ronnie Tung Ping Poon's work exemplifies the impact of innovation in healthcare, particularly in the realm of oncology. His patents and research hold potential for transforming cancer diagnosis and treatment, solidifying his status as an influential inventor in the medical field. As he continues to navigate the complexities of cancer research, his contributions will undoubtedly play a crucial role in enhancing patient care and treatment efficacy.